RICHLAND, WA -- (Marketwired) -- 08/29/13 -- (NYSE MKT: ISR), specializing in the development, manufacture, and sale of isotope-based medical products and devices for the treatment of cancer and other malignant diseases primarily in the United States, today announced the re-pricing of an underwritt ...
↧